https://sensesandsciences.com/index.php/Senses/issue/feed Senses and Sciences 2025-11-23T14:30:59+00:00 Giuseppe La Torre giuseppe.latorre@uniroma1.it Open Journal Systems https://sensesandsciences.com/index.php/Senses/article/view/335 Radiation induced lymphedema in patients received hypofractionation schedules in adjuvant radiotherapy settings for non-metastatic breast cancer 2025-11-23T14:30:59+00:00 Amr Ameen dr.amr.munir@gmail.com Ahmed Badawy ahmed.ashour@alexmed.edu.eg Maher Soliman maher.soliman@alexmed.edu.eg Ashraf Elenbaby elenbaby@hotmail.com <p><strong>Background</strong></p> <p>Hypofractionation was introduced in early breast cancer based on multiple clinical trials. The rationale behind hypofractionation is to deliver high dose per fraction over short duration without compromising the local control. The short fractionation was limited to early breast cancer with BCS. However, there are few data regarding the short course after mastectomy. In node positive disease, the role of hypofractionation schedules is limited due to afraid of late toxicity specially lymphedema. We conducted this study to assess the lymphedema in patient with high-risk early disease who received either moderate or ultra hypofractionation schedules.</p> <p><strong>Materials and methods</strong></p> <p>One hundred patients received adjuvant radiotherapy using moderate or ultra hypofractionation schedules with either pT1-3 or pN0-1 were subjected for pretreatment lymphedema assessment using International Society of Lymphology staging of lymphoedema and then after radiotherapy every 3 months for 4 years.</p> <p><strong>Aim of the work </strong></p> <p><strong>The primary end point:</strong> To assess the radiation induced lymphedema incidence and to assess factors affecting lymphedema before and after radiotherapy.</p> <p><strong>Results</strong></p> <p>Patients with modified radical mastectomy were associated with high incidence of lymphedema with significant difference compared to BCS. Nighty seven percent of patients with lymphedema had axillary dissection with significant difference compared to sentinel Lymph node biopsy. After radiotherapy, the ratio of positive node to total node dissected was associated with high incidence of lymphedema.</p> <p>In multivariate analysis. It was found that only axillary dissection was the most significant factor affecting lymphedema after 4 years with 4.9 odds ratio. Using either moderate hypofractionation or ultrahypofractionation had no effect on lymphedema incidence.</p> <p><strong>Conclusion</strong></p> <p>Axillary dissection is the most important risk factor for the development of lymphedema specially after radiotherapy. A higher dose per fraction did not increase the incidence of lymphedema even in patients with high-risk node positive early breast cancer.</p> 2025-11-23T14:29:43+00:00 ##submission.copyrightStatement## https://sensesandsciences.com/index.php/Senses/article/view/336 Histopathological Study of Thrombi Retrieved from Cerebral Arteries following Mechanical Thrombectomy and Correlation with Radiographic, Clinical Outcomes and Origin of the Thrombus 2025-11-23T14:30:59+00:00 Abdulrahman Mostafa Ibrahim abdulrahman.mostafa241@gmail.com Rania Gaber Mohamed Ali rgm2006isa@yahoo.com Hany Mohamed Ibrahim Eldeep hanys5252@gmail.com Ossama Yassin Mansour Yassinossama@yahoo.com <p><strong>Background:</strong> Advancements in endovascular methods for addressing strokes resulting from major cerebral &nbsp;&nbsp;artery occlusions have facilitated the examination of recovered thrombus material, offering a significant avenue to improve the determination of stroke causes. This study aimed to investigate the immuno-histopathological features of clots retrieved through mechanical thrombectomy in individuals with acute ischemic stroke (AIS).</p> <p><strong>Methods:</strong> A total of 22 consecutive patients, aged 18 years or older, were included in this study. All had experienced an acute ischemic stroke caused by large vessel occlusion (LVO) and underwent endovascular thrombectomy at our facility between September 2021 and June 2023. The thrombi extracted during the procedure were subsequently subjected to detailed histopathological analysis.</p> <p><strong>Results:</strong> There were significant differences found between clot composition (WBC, fibrin, and RBC groups) and several factors including ischemic heart disease (IHD), stroke cause, ASPECT score, collateral score, NIHSS immediately post-procedure, mRS at discharge, procedure duration, eTICI, number of passes, and brain edema (P&lt;0.05). The ASPECT and collateral scores were higher in the WBC group compared to the fibrin and RBC groups (P&lt;0.05). Additionally, clot composition influenced immediate post-procedural NIHSS, mRS at discharge, brain edema, and hemorrhage (P&lt;0.05). The fibrin group had a significantly longer procedure duration, and more passes compared to the RBC and WBC groups (P&lt;0.05).</p> <p><strong>Conclusions: </strong>Clot composition was linked to hemorrhage, mRS, and discharge outcomes. Higher CD3 and CD31 levels were associated with better outcomes and higher ASPECT scores. Post-intervention NIHSS and procedure parameters (duration, eTICI) were also associated with CD3.</p> 2025-11-23T14:30:08+00:00 ##submission.copyrightStatement## https://sensesandsciences.com/index.php/Senses/article/view/337 Retrospective Analysis of the Effect of Radiation Boost versus No Boost Using Hypofractionation Schedule on Breast Cancer Loco-Regional Recurrence 2025-11-23T14:30:59+00:00 Ahmed Shama dr.ahmedshama@gmail.com Amr Abdelmoneim Mahmoud Amr_Abdelkader@med.kfs.edu.eg Emad Sadqa e_sadaka@hotmail.com <p><strong>Background:</strong> Radiation treatment to the preserved breast following breast-conserving surgery lowers the mortality risk from breast cancer and cuts the disease's recurrence rate in half. The aim of this work was to define the effectiveness and feasibility of two different hypo fractionation schedules in the adjuvant settings of non-metastatic breast cancer.</p> <p><strong>Methods:</strong> This study included 100 patients, aged ≥50 years old, who had breast conservative surgery or mastectomy, invasive breast cancer with p T1-3, p N0-2 and non-metastatic breast cancer verified by clinical evaluations and imaging (X-ray chest and ultrasound or CT scan chest and abdomen). Patients were randomized into two equal groups: Control arm: received standard 40.05 gray (2.67 Gy/ fx) over 15 fractions over 3 weeks with or without boost and experimental arm: received 26 Gray (5.2) over 5 fractions over 1.5 weeks using one of the offered regimens.</p> <p><strong>Results: </strong>Lymph vascular invasion (LVI), Adjuvant treatment, clinical target volume (CTV, level1, level 2 and level 3 were significantly lower in boost group than non-boost group (P&lt;0.05). Supraclavicular nodes (SCV), ipsilateral lung v5, mean lung, mean heart, pigmentation and erythema were significantly lower in boost group than non-boost group (P&lt;0.05). Skin toxicity, recurrence and distant recurrence were not significantly different between both groups.&nbsp; Overall survival (OS) was statistically lower in boost group than non-boost group (P&lt;0.05).</p> <p><strong>Conclusions: </strong>Boost group have statically significant lower LVI, Adjuvant treatment, CTV, level1, level2 and level3, SCV nodes, ipsilateral lung V5, mean lung, and mean heart than non-boost group and complication of radiation after mastectomy of breast cancer are less pigmentation, erythema and OS while, recurrence and distant recurrence are indifferent to conventional surgery without post radiation.</p> 2025-11-23T14:30:33+00:00 ##submission.copyrightStatement##